Elekta offers doctors free use of ProKnow software to facilitate cancer treatments during COVID-19
CRAWLEY, United Kingdom, April 21, 2020 – Elekta (EKTA-B.ST) announced today that it is making its popular ProKnow software available to clinicians free of charge during the COVID-19 pandemic.ProKnow is used to collect and analyze data to support ongoing improvement of anatomy contouring and treatment plans. By making it freely available to all clinicians, Elekta hopes that this will remove the roadblocks caused by lockdown or isolation regulations in different countries. As a cloud-based solution, clinicians could use ProKnow from home for highly skilled procedures such as tumor contouring.
Elekta CEO, Richard Hausmann, says: “It is very disheartening to hear about patients who are unable to receive the radiation therapy they need due to restrictions caused by the coronavirus. To support clinicians and their patients and avoid further delays, Elekta will provide free access to ProKnow.”
ProKnow is designed to improve quality in radiation therapy worldwide. It offers unique capabilities for data management, distribution of contouring and plan review tasks across a network, and big data analytics that integrate comparative effectiveness and patient outcomes analysis into daily routine and decision support. ProKnow is deployed quickly and easily through Elekta Axis. Axis is the new fully managed services cloud environment, that has been built and automated in Microsoft Azure. Axis allows ProKnow to be used securely on any device anywhere for clinicians.
For more information about ProKnow*, visit https://proknow.com/
ProKnow received both US FDA 510(k) premarket clearance and CE mark earlier this year.
2020.*Commercial availability of ProKnow currently limited to countries that accept user documentation in English.
# # #
For further information, please contact:
Mattias Thorsson, Head of Corporate Communications and Public Affairs
Tel: +46 70 865 8012, e-mail: [email protected]
Time zone: CET: Central European Time
Raven Canzeri, Global Public Relations Manager, Elekta
Tel: +1 770-670-2524, e-mail: [email protected]
Time zone: ET: Eastern Time
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.